Evidence map›Paper›PMID 42100922›Full record

ArticlemAbs2026

Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties.

Na-Young Kwon, Chloe N Brown, Hsin-Ting Chen, Steven R Cottle, Ronan M Kelly, Bryan E Jones, William F Weiss, Peter M Tessier

Abstract read
In one paragraph

Article in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Na-Young KwonDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0003-0128-7173
Chloe N BrownDepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.ORCID 0009-0000-9184-8610
Hsin-Ting ChenDepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-5217-5222
Steven R CottleBioTechnology Discovery Research, Lilly Technology Center - North, Eli Lilly and Company, Indianapolis, IN, USA.
Ronan M KellyBioTechnology Discovery Research, Lilly Technology Center - North, Eli Lilly and Company, Indianapolis, IN, USA.ORCID 0000-0003-3818-5269
Bryan E JonesBioTechnology Discovery Research, Lilly BioTechnology Center, Eli Lilly and Company, San Diego, CA, USA.
William F WeissBioTechnology Discovery Research, Lilly Technology Center - North, Eli Lilly and Company, Indianapolis, IN, USA.
Peter M TessierDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-3220-007X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To meet the widespread demand for subcutaneous delivery of antibody therapeutics, candidates with low viscosity, high solubility, and/or low aggregation propensity in concentrated formulations must be identified. Moreover, early identification of candidates with low self-association increases the likelihood of success at later stages of the development process. Here, we experimentally profile the self-association behavior of a panel of clinical-stage antibodies as a function of pH, excipient content, and antibody isotype. We find that acidic formulations (pH 5) with proline (200 mM) are most effective at suppressing self-association for both IgG1 and IgG4 variants. Moreover, our self-association measurements are correlated with antibody viscosity measurements and inversely correlated with antibody recovery after their concentration using membrane filters. Notably, we developed interpretable machine learning-based classifier and regressor models for predicting IgG1 and IgG4 self-association and demonstrated that they identify antibodies with favorable high-concentration properties. These findings are expected to improve the antibody development process by facilitating the identification of drug-like molecules during their discovery and optimization.

Indexed as

Antibodies, MonoclonalImmunoglobulin GMachine LearningHumansHydrogen-Ion ConcentrationViscosityAntibodies, MonoclonalImmunoglobulin GAggregationelectrostatichydrophobicisoelectric pointisotypemAbself-interactionsolubilityviscosity

Identifiers

PMID42100922
PMCPMC13166204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.